Skip to content

Self Medication in Odontology (AUDE)

Self Medication and Pulpal and Periapical Dental Pain

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04949126
Acronym
AUDE
Enrollment
940
Registered
2021-07-02
Start date
2021-06-15
Completion date
2023-05-12
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Anxiety, Dental Pain

Keywords

Anxiety, Pulpal pain, Self medication, Observational study

Brief summary

To describe and understand the self-medication behaviours of a population of adults coming to the Clermont-Ferrand dentistry department for acute pain of pulpal origin and of a population of adults coming to the specific care unit of the Clermont-Ferrand dentistry department or the Riom hospital for treatment under general anaesthesia.

Detailed description

Self-medication behaviour will be studied by means of a questionnaire. Questionnaires on insecurity, anxiety about dental care, items related to the ingestion function of the International Classification of Functioning, Disability and Health (ICF), a visual analogue pain assessment scale and the PCS-CF pain dramatisation scale will also be used.

Interventions

BEHAVIORALquestionnaire

questionnaires of precarity, dental anxiety, self medication, pain

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient, male or female, coming to consult in the Clermont-Ferrand or Riom Hospital for acute pain of pulp origin and periapical OR eligible for dental treatment under general anesthesia in a context phobic. * Understanding and practicing French * giving informed consent to participate in research. * Affiliation to a Social Security scheme.

Exclusion criteria

* Patients under guardianship. * Patient's refusal to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
description of the self-medication behavioursday 0evaluated by patient interrogation

Secondary

MeasureTime frameDescription
level of anxietyday 0: evaluated with IDAF 4C (anxiety module between 8-40, phobia module between 5-10 and anxious situations between 10 and 50), the higher the score, the more anxious the patient is
level of insecurityday 0evaluated by questionnaire (EPICES (the patient is in situation of insecurity if the score is higher than 30))
description of the oral health with the related to the ingestion function of the International Classification of Functioning, Disability and Health (ICF)day 0each item is evaluated with a Lickert scale
visual analogue pain assessment scale and the PCS-CF pain dramatisation scaleDay 0PCS-CF scale is evaluated between 0 and 52, the higher the score, the more patient is over reacting faced with pain

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026